Absorption |
Blood-Brain Barrier | BBB- | 0.8674 |
Human Intestinal Absorption | HIA+ | 0.7702 |
Caco-2 Permeability | Caco2- | 0.8673 |
P-glycoprotein Substrate | Substrate | 0.7735 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.8020 |
Non-inhibitor | 0.7326 |
Renal Organic Cation Transporter | Non-inhibitor | 0.8786 |
Distribution |
Subcellular localization | Mitochondria | 0.6955 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.7525 |
CYP450 2D6 Substrate | Non-substrate | 0.8534 |
CYP450 3A4 Substrate | Non-substrate | 0.5372 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.8338 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.9090 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.9328 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.9145 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.9484 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8667 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9464 |
Inhibitor | 0.5723 |
AMES Toxicity | Non AMES toxic | 0.9132 |
Carcinogens | Non-carcinogens | 0.9563 |
Fish Toxicity | High FHMT | 0.8796 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.9935 |
Honey Bee Toxicity | High HBT | 0.5855 |
Biodegradation | Not ready biodegradable | 0.7346 |
Acute Oral Toxicity | III | 0.6752 |
Carcinogenicity (Three-class) | Non-required | 0.6732 |